PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 17, 2026BMJ Case Reports0 citations

Delayed-onset, persisting autoimmune heparin-induced thrombocytopenia with thrombosis following craniofacial surgery

View Full Paper
VWValerie WillTTTobias TritschlerCMCaterina E. Marx

Key Points

  • This report examines a case of delayed-onset autoimmune heparin-induced thrombocytopenia (HIT) post-surgery.
  • Patient received prophylactic anticoagulation with unfractionated heparin after craniofacial surgery.
  • Observation of thrombocytopenia and thrombosis following cessation of heparin.
  • Utilized HIT-antibody immunoassay and functional assay for diagnosis.
  • Patient developed pulmonary embolism and worsening thrombocytopenia four days after stopping heparin.
  • HIT antibodies were strongly positive, confirming delayed-onset autoimmune HIT.
  • Treatment with immunoglobulin led to a rapid recovery of platelet counts.

Abstract

We report a case of a patient who developed delayed-onset, persisting autoimmune heparin-induced thrombocytopenia (HIT) following prophylactic anticoagulation with unfractionated heparin (UFH) after surgical treatment of a complex midfacial and mandibular fracture. Four days after stopping prophylactic anticoagulation, the patient developed pulmonary embolism and mild thrombocytopenia. HIT was initially not suspected and therapeutic anticoagulation was started. The patient subsequently developed severe thrombocytopenia consistent with HIT. Despite cessation of UFH and initiation of argatroban, thrombocytopenia did not improve. A HIT-antibody immunoassay and functional assay (HIPA) was strongly positive, and HIPA showed activity even in the absence of heparin, supporting the diagnosis of delayed-onset, persisting autoimmune HIT (aHIT). The patient was treated with immunoglobulin, resulting in a rapid recovery of platelet counts. This case highlights the importance of early recognition and appropriate management of aHIT, especially in patients with persisting thrombocytopenia despite standard HIT therapy.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Will et al. (2026) studied this question.

synapsesocial.com/papers/6994055d4e9c9e835dfd62a9https://doi.org/10.1136/bcr-2025-269479
Ask AI
Helpful
Bookmark
Share
View Full Paper